Measured parameters of dose escalation of Oncaspar

Mona Ali Mahmoud Assar; Martina Hüffel; Mamdouh Afify; Ralf Weiskirchen; Albrecht Eisert; René H. Tolba; Julia Steitz

doi:10.6084/m9.figshare.17032946.v2

Dataset

Measured parameters of dose escalation study of Oncaspar

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Dataset

Dose escalation of Oncaspar parameters

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Dataset

Results

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Dataset

Results of histopathological analysis

Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, René H. Tolba, Julia Steitz

Article2021

Abstract CT015: A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma

Giselle L. Saulnier Sholler, Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacquline Kraveka, Peter Carmeliet, A. De Deene, Rakesh K. Jain

Measured parameters of dose escalation of Oncaspar

Abstract

Discussion(0)

Related publications

Measured parameters of dose escalation study of Oncaspar

Dose escalation of Oncaspar parameters

Results

Results of histopathological analysis

Abstract CT015: A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma